Nona Health Review

Overview

Nona Health is a women-focused GLP-1 telehealth platform founded around 2022 that positions itself as a more thoughtful alternative to generic weight management services. Rather than treating all patients identically, Nona's intake process incorporates hormonal and reproductive health context — relevant for women whose weight management goals intersect with perimenopause, PCOS, thyroid conditions, or other hormonally-mediated factors.

The platform operates on an asynchronous care model, meaning patients complete intake online and are reviewed by a physician without requiring a scheduled video call. This streamlines access but limits the depth of real-time clinical conversation during the initial evaluation.

Transparency note: Nona Health is a newer, smaller platform with limited independent reviews and third-party coverage as of April 2026. Much of what we know comes from the company's own materials. We recommend verifying all program details — medications available, pricing, and physician credentials — directly at nonahealth.com before enrolling.

April 2026 regulatory context: The FDA's enforcement actions against compounded semaglutide and tirzepatide directly affect platforms like Nona that have relied on compounded formulations. As of early 2026, the FDA has removed semaglutide from its drug shortage list, which restricts the legal basis for compounding pharmacies to produce it. Patients should confirm whether Nona's current prescriptions are compounded or branded, and verify that any pharmacy used is operating in compliance with current FDA guidance.

Medications Offered

Nona Health likely offers compounded semaglutide and potentially compounded tirzepatide, based on its positioning as an accessible GLP-1 platform. Whether branded options (Wegovy, Zepbound) are available through Nona is not publicly confirmed.

Verify the current formulary — including compounding status and pharmacy partnerships — at nonahealth.com.

Orforglipron, the first oral GLP-1 receptor agonist, has not received FDA approval as of April 2026 (PDUFA date: April 10, 2026) and is not available through any telehealth platform.

Pricing

Pricing is not independently confirmed. Verify current rates, what is included in each tier, and whether the medication cost is bundled or billed separately at nonahealth.com.

States Served

Nona Health's telehealth services are limited to states where its licensed providers are authorized to prescribe. Verify state availability at nonahealth.com before starting the intake process.

Insurance

GLP-1 insurance coverage depends on your specific plan, the medication prescribed, and your diagnosed indication. Nona Health's insurance acceptance is not publicly confirmed — verify at nonahealth.com.

Consultation Process

1. Visit nonahealth.com and complete the online health intake.
2. Provide information about your weight history, health goals, and relevant hormonal or reproductive health context.
3. A licensed physician reviews your intake asynchronously.
4. If you qualify, a prescription is sent to a partner pharmacy.
5. Medication is shipped to your address (verify shipping states at enrollment).
6. Ongoing care — including dose adjustments and check-ins — is managed through the platform's messaging system. Confirm frequency and format at intake.

Pros

• Women-focused intake considers hormonal and reproductive health context, which generic platforms often ignore
• Asynchronous model removes scheduling friction for busy patients
• Positioned as a streamlined, accessible alternative to larger, higher-cost platforms

Cons

• Newer platform with limited independent reviews — difficult to evaluate quality of care independently
• Compounding regulatory environment in April 2026 creates uncertainty about medication availability and legal status
• Async-only care limits real-time clinical dialogue, which may not suit all patients
• Physician credentials and pharmacy licensing are not prominently disclosed publicly — ask directly before enrolling

Best For

Women seeking a GLP-1 telehealth provider that takes hormonal health context into account during intake. Patients who are comfortable with an async care model and are willing to do direct due diligence on a smaller platform before enrolling.

Editorial Verdict

Nona Health addresses a real gap: most GLP-1 telehealth platforms treat weight management in isolation, without considering how hormonal health interacts with weight in women. That's a meaningful differentiator if the clinical intake genuinely uses that information to inform care. However, as a newer platform with limited public reviews, the editorial team cannot independently verify care quality, physician credentials, or the current status of its compounded medication supply chain. Verify all details directly at nonahealth.com and confirm pharmacy compliance before enrolling.

Related Content

• How Much Does Semaglutide Cost?
• Who Qualifies for GLP-1 Medications?
• Mochi Health vs. Henry Meds